Condition: Locally Advanced Nasopharyngeal Carcinoma · Sponsor: First Affiliated Hospital, Sun Yat-Sen University
This trial is a multi-center phase III clinical trial. The purpose of this trial is to explore whether 2 cycles induction chemotherapy combined with concurrent chemoradiotherapy is not inferior to 3 cycles induction chemotherapy combined with concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
This description comes directly from the study's public registry record.
Cheng-Tao Wang · +862087755766 · wangcht5@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital, Sun Yat-Sen University | Guangzhou, Other (Non U.s.), China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05860868